Page 55 - Sohini Das

Breather for Natco in Novartis cardiac drug case from Delhi High Court

May open floodgates for Indian drugmakers to launch the generic version of the drug as early as next week

At 3.8 million units, PV sales rev up to highest ever in 2022: Siam

Data showed that passenger vehicle sales grew by 23 per cent in 2022 compared to the previous year to touch 3.79 million units

Roadblocks on exit route: GM, Ford struggle with lingering staff problems

The two Detroit majors are struggling with lingering employee problems as they seek to drive out of the Indian market

WHO issues a 'medical product alert' for Marion Biotech cough syrup

The WHO has said Marion Biotech had not provided guarantees to them on the safety and quality of these products

Cummins India to start production of fuel-agnostic engines this year

Firm says it will start with LNG-hydrogen platform; India to be a sourcing hub

Hospital sector likely to post healthy growth in FY23: ICRA report

Aggregate bed occupancy seen at 64% due to 'sustained improvement in demand', says agency

Luxury carmakers likely to see faster electric vehicle transition

Buyers less price-sensitive; Mercedes, BMW expect double-digit growth

Cough syrup deaths: Marion's licence suspended over no reply to show cause

Marion's licence cancelled over no reply to show cause

Covaxin shows 'positive' results in phase 2/3 studies in US: Ocugen

If approved, will become the first India-developed vax to be commercialised in the US

New Omicron variants are not causing case spike or mortality: Govt

The Union Ministry of Health and Family Welfare has initiated random testing of international travelers arriving at various Airports from December 24, 2022

India overtakes Japan to take third spot among largest vehicle markets

According to Siam, 4.13 million vehicles - including passenger and commercial - were sold in the country between January and November 2022

Lal PathLabs targets leadership position in west India in 5 years

Om Manchanda, MD, Dr Lal Pathlabs said that the contribution of the west zone has gone up from 6 percent in FY15 to 8 percent in FY20 and 15 percent in the first half of FY23

Price growth drove India's pharmaceutical sales in 2022, shows data

Data shows that in calendar year 2022, price driven growth rate has been 6 per cent; growth from new products has been 1.7 percent, while volume growth has been zero

Around 21 API projects come up under the PLI scheme, shows data

These units have an installed capacity of 33,895 tonnes

No reason to worry about new Covid variant Kraken in India yet: Experts

US Center for Disease Control and Prevention shows that from just 1 percent of the Covid19 cases in the US in Dec 2022, Kraken variant now accounts for almost 41 percent of all the Covid19 infections

XBB prevalent Covid variant in international travellers, show India's tests

Omicron variant blamed for 40% of all cases being reported in the US

Urban India leaves rural way behind as vaccinations surge 44% nationwide

This is despite the prevalence of a much larger population in the country's villages and a greater number of vaccination centres in these areas, compared to urban

Top carmakers post double-digit export growth with Maruti at the wheel

Clock 11% growth in the first 11 months of 2022

Granules India ties up with Greenko Group for 'green' pharma zones

As a part of the partnership, Granules and Greenko ZeroC will develop and promote state-of-the-art Integrated Green Pharmaceutical Zones (GPZ) with first collaboration in Kakinada, Andhra Pradesh

BDR Pharma prostate cancer drug at 1/3rd of innovator brand price

The price for a bottle of 60 tablets is Rs 22,500 and for a bottle of 120 tablets is Rs 45,000